IDEXX Laboratories
IDXX
#575
Rank
NZ$73.49 B
Marketcap
NZ$931.66
Share price
3.21%
Change (1 day)
5.92%
Change (1 year)

P/E ratio for IDEXX Laboratories (IDXX)

P/E ratio as of May 2026 (TTM): 39.8

According to IDEXX Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 39.8387. At the end of 2025 the company had a P/E ratio of 51.3.

P/E ratio history for IDEXX Laboratories from 2001 to 2026

PE ratio at the end of each year

Year P/E ratio Change
202551.333.71%
202438.4-29.66%
202354.68.63%
202250.2-33.31%
202175.32.64%
202073.439.42%
201952.622.55%
201843.0-17.58%
201752.110.24%
201647.334.56%
201535.1-14.67%
201441.236.68%
201330.15.21%
201228.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Abbott Laboratories
ABT
24.4-38.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
24.3-39.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Henry Schein
HSIC
21.8-45.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
35.0-12.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-3.05-107.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Heska Corporation
HSKA
-62.2-256.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Petco
WOOF
-255-740.08%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.